The 2022 Statement of Work (SOW) for Community Treatment Services (CTS) outlines the requirements for contractors providing substance use disorder (SUD), mental health (MH), and sex offender treatment (SOT) services to offenders in the Bureau of Prisons' custody. The SOW emphasizes the Bureau's commitment to offering evidence-based treatment aimed at reducing recidivism and promoting mental well-being. Key treatment modalities include Cognitive Behavioral Therapy (CBT), medication-assisted treatment (MAT), and various mental health programs tailored to specific offender needs.
The document details the scope of work, including treatment referrals, assessments, counseling services, and monitoring medication, underscoring the necessity of thorough documentation and adherence to legal standards such as HIPAA. It outlines the significance of individualized treatment plans and collaborative engagement with offenders.
Compliance with the SOW is crucial, as the Bureau retains the right to modify contracts and conduct inspections to ensure quality. The SOW serves as a framework for contractors to provide essential support for rehabilitation, thereby contributing to public safety and successful offender reintegration into society.
The U.S. Department of Justice's Federal Bureau of Prisons is seeking qualified vendors to provide outpatient treatment services for substance use disorder, mental health, and sex offender treatment for federally incarcerated individuals (AICs) in community placements in Albany, New York. The Bureau operates numerous institutions across the U.S. and aims to deliver high-quality, evidence-based treatment services nationwide, particularly for AICs in Residential Reentry Centers (RRCs) and home confinement situations. This Sources Sought Notice is intended to assess the availability of competent providers capable of fulfilling these needs within a five-mile radius of Albany City Hall while adhering to public transportation accessibility requirements. The Bureau is soliciting feedback on the feasibility of providing comprehensive treatment services and invites vendors to share insights regarding the challenges of meeting these requirements, including regulatory constraints and their operational capabilities. Responses to this notice are not binding and will inform future acquisition plans. Interested providers must submit their information by the specified deadline via email, while ensuring compliance with proprietary and regulatory guidelines.